Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 142 | 2024 | 857 | 32.550 |
Why?
|
Infertility, Female | 32 | 2024 | 760 | 5.260 |
Why?
|
Infertility | 30 | 2023 | 654 | 5.210 |
Why?
|
Fertilization in Vitro | 59 | 2023 | 1292 | 4.510 |
Why?
|
Reproductive Techniques, Assisted | 32 | 2023 | 496 | 4.050 |
Why?
|
Leiomyoma | 15 | 2024 | 636 | 3.470 |
Why?
|
Pelvic Pain | 25 | 2024 | 292 | 3.370 |
Why?
|
Nurses | 26 | 2024 | 2477 | 3.130 |
Why?
|
Fertility | 20 | 2024 | 769 | 2.230 |
Why?
|
Peritoneal Diseases | 4 | 2021 | 75 | 1.850 |
Why?
|
Menstrual Cycle | 15 | 2024 | 539 | 1.830 |
Why?
|
Abortion, Spontaneous | 18 | 2021 | 532 | 1.770 |
Why?
|
Female | 362 | 2024 | 392203 | 1.670 |
Why?
|
Women's Health | 10 | 2023 | 2066 | 1.580 |
Why?
|
Uterine Neoplasms | 11 | 2024 | 1420 | 1.560 |
Why?
|
Embryo Transfer | 25 | 2023 | 522 | 1.560 |
Why?
|
Dyspareunia | 5 | 2023 | 47 | 1.530 |
Why?
|
Adult | 255 | 2024 | 220995 | 1.520 |
Why?
|
Premenopause | 15 | 2024 | 1038 | 1.510 |
Why?
|
Pregnancy | 128 | 2024 | 29869 | 1.490 |
Why?
|
Premature Birth | 15 | 2022 | 1782 | 1.420 |
Why?
|
Reproductive Medicine | 5 | 2022 | 99 | 1.380 |
Why?
|
Dairy Products | 5 | 2020 | 490 | 1.380 |
Why?
|
Dysmenorrhea | 9 | 2024 | 94 | 1.340 |
Why?
|
Prospective Studies | 91 | 2024 | 54364 | 1.330 |
Why?
|
Follicular Fluid | 7 | 2019 | 92 | 1.280 |
Why?
|
Laparoscopy | 20 | 2024 | 2030 | 1.280 |
Why?
|
Pregnancy Rate | 30 | 2022 | 648 | 1.270 |
Why?
|
Hysterectomy | 10 | 2024 | 856 | 1.240 |
Why?
|
Risk Factors | 107 | 2024 | 74128 | 1.220 |
Why?
|
Live Birth | 21 | 2022 | 510 | 1.190 |
Why?
|
Pregnancy Outcome | 34 | 2022 | 2921 | 1.190 |
Why?
|
Humans | 370 | 2024 | 760740 | 1.160 |
Why?
|
Cohort Studies | 74 | 2024 | 41464 | 1.110 |
Why?
|
Pregnancy Complications | 9 | 2022 | 2948 | 1.110 |
Why?
|
Parity | 11 | 2023 | 924 | 1.100 |
Why?
|
Endometrium | 7 | 2021 | 403 | 1.100 |
Why?
|
Oocytes | 9 | 2023 | 1166 | 1.020 |
Why?
|
Proportional Hazards Models | 30 | 2024 | 12448 | 0.990 |
Why?
|
Body Size | 5 | 2013 | 463 | 0.980 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 407 | 0.980 |
Why?
|
Pregnancy, Multiple | 10 | 2022 | 215 | 0.950 |
Why?
|
Sterilization, Tubal | 3 | 2023 | 75 | 0.930 |
Why?
|
Ovarian Neoplasms | 14 | 2024 | 4849 | 0.910 |
Why?
|
Gonadal Steroid Hormones | 10 | 2023 | 702 | 0.910 |
Why?
|
Adolescent | 85 | 2024 | 88247 | 0.870 |
Why?
|
Public Opinion | 6 | 2017 | 484 | 0.810 |
Why?
|
Cardiovascular Diseases | 16 | 2024 | 15498 | 0.810 |
Why?
|
Embryo Implantation | 14 | 2023 | 270 | 0.770 |
Why?
|
Diet | 13 | 2024 | 8049 | 0.770 |
Why?
|
Oocyte Retrieval | 11 | 2021 | 160 | 0.750 |
Why?
|
Tobacco Smoke Pollution | 6 | 2020 | 820 | 0.740 |
Why?
|
Incidence | 32 | 2024 | 21339 | 0.740 |
Why?
|
Hypercholesterolemia | 6 | 2022 | 1141 | 0.740 |
Why?
|
Menopause, Premature | 1 | 2022 | 124 | 0.710 |
Why?
|
Uterus | 6 | 2022 | 649 | 0.710 |
Why?
|
Young Adult | 75 | 2024 | 59191 | 0.700 |
Why?
|
Ascitic Fluid | 1 | 2020 | 189 | 0.700 |
Why?
|
Calcium, Dietary | 2 | 2013 | 529 | 0.700 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2022 | 376 | 0.690 |
Why?
|
Pre-Eclampsia | 4 | 2022 | 1230 | 0.690 |
Why?
|
Risk | 22 | 2019 | 9603 | 0.690 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2017 | 1932 | 0.680 |
Why?
|
Diethylstilbestrol | 2 | 2013 | 87 | 0.680 |
Why?
|
United States | 63 | 2024 | 72292 | 0.670 |
Why?
|
Infertility, Male | 3 | 2015 | 396 | 0.670 |
Why?
|
Dietary Fats | 3 | 2020 | 1995 | 0.670 |
Why?
|
Magnesium | 2 | 2013 | 804 | 0.670 |
Why?
|
Mastocytosis, Systemic | 1 | 2021 | 103 | 0.660 |
Why?
|
Arthritis, Psoriatic | 1 | 2022 | 219 | 0.650 |
Why?
|
Research Support as Topic | 1 | 2023 | 697 | 0.630 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 4 | 2017 | 416 | 0.630 |
Why?
|
Life Style | 10 | 2020 | 3907 | 0.630 |
Why?
|
Hysterectomy, Vaginal | 2 | 2016 | 28 | 0.630 |
Why?
|
Diabetes, Gestational | 4 | 2022 | 1250 | 0.630 |
Why?
|
Delayed Diagnosis | 7 | 2024 | 463 | 0.630 |
Why?
|
Environmental Exposure | 10 | 2019 | 4483 | 0.620 |
Why?
|
Case-Control Studies | 32 | 2024 | 22153 | 0.620 |
Why?
|
Ovarian Diseases | 1 | 2019 | 136 | 0.620 |
Why?
|
Poultry | 1 | 2018 | 80 | 0.610 |
Why?
|
Coronary Disease | 4 | 2023 | 5911 | 0.610 |
Why?
|
Gynecology | 3 | 2020 | 526 | 0.610 |
Why?
|
Air Pollution | 4 | 2019 | 2355 | 0.600 |
Why?
|
Middle Aged | 95 | 2024 | 220603 | 0.590 |
Why?
|
Reproduction | 5 | 2023 | 646 | 0.580 |
Why?
|
Body Mass Index | 29 | 2017 | 12942 | 0.570 |
Why?
|
Longitudinal Studies | 22 | 2024 | 14599 | 0.570 |
Why?
|
Prolactin | 5 | 2017 | 625 | 0.560 |
Why?
|
Adult Survivors of Child Abuse | 2 | 2018 | 294 | 0.560 |
Why?
|
Reproductive History | 4 | 2023 | 210 | 0.540 |
Why?
|
Quality of Life | 13 | 2024 | 13359 | 0.530 |
Why?
|
Child Abuse, Sexual | 2 | 2018 | 403 | 0.520 |
Why?
|
Anthropometry | 4 | 2012 | 1338 | 0.520 |
Why?
|
Vegetables | 4 | 2022 | 1192 | 0.510 |
Why?
|
Fetal Death | 2 | 2015 | 435 | 0.510 |
Why?
|
Cryopreservation | 7 | 2021 | 728 | 0.510 |
Why?
|
Obesity | 19 | 2023 | 12934 | 0.500 |
Why?
|
Comorbidity | 7 | 2024 | 10507 | 0.500 |
Why?
|
Tissue Banks | 3 | 2014 | 184 | 0.500 |
Why?
|
Cross-Sectional Studies | 34 | 2024 | 26065 | 0.490 |
Why?
|
Cholecalciferol | 1 | 2020 | 553 | 0.490 |
Why?
|
Genital Diseases, Female | 1 | 2016 | 192 | 0.490 |
Why?
|
Seafood | 1 | 2018 | 393 | 0.480 |
Why?
|
Age Factors | 18 | 2021 | 18381 | 0.480 |
Why?
|
Physical Examination | 2 | 2024 | 1254 | 0.480 |
Why?
|
Odds Ratio | 22 | 2020 | 9644 | 0.480 |
Why?
|
Contraceptives, Oral, Hormonal | 4 | 2020 | 190 | 0.480 |
Why?
|
Fruit | 3 | 2022 | 1158 | 0.480 |
Why?
|
Self-Injurious Behavior | 1 | 2021 | 566 | 0.480 |
Why?
|
Vitamins | 2 | 2013 | 1635 | 0.470 |
Why?
|
Air Pollutants | 4 | 2019 | 2893 | 0.470 |
Why?
|
Semen | 2 | 2023 | 347 | 0.470 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2020 | 1390 | 0.470 |
Why?
|
Prevalence | 17 | 2024 | 15702 | 0.470 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 452 | 0.460 |
Why?
|
Breast Neoplasms | 19 | 2023 | 20988 | 0.460 |
Why?
|
Neoplasms, Glandular and Epithelial | 5 | 2016 | 487 | 0.460 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2022 | 517 | 0.460 |
Why?
|
Menstruation Disturbances | 3 | 2020 | 143 | 0.450 |
Why?
|
Genome-Wide Association Study | 12 | 2024 | 12661 | 0.450 |
Why?
|
Registries | 11 | 2022 | 8209 | 0.450 |
Why?
|
Psoriasis | 1 | 2022 | 944 | 0.450 |
Why?
|
Statistics as Topic | 3 | 2017 | 2358 | 0.450 |
Why?
|
Endometrial Neoplasms | 3 | 2022 | 1365 | 0.430 |
Why?
|
Breast Diseases | 1 | 2016 | 443 | 0.430 |
Why?
|
Infant, Newborn | 23 | 2022 | 26183 | 0.430 |
Why?
|
Waist-Hip Ratio | 3 | 2013 | 518 | 0.420 |
Why?
|
Arthritis, Rheumatoid | 2 | 2021 | 3752 | 0.420 |
Why?
|
Neoplasms | 12 | 2023 | 22131 | 0.420 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 733 | 0.420 |
Why?
|
Genetic Loci | 4 | 2017 | 2624 | 0.420 |
Why?
|
Alcohol Drinking | 5 | 2017 | 4028 | 0.410 |
Why?
|
Phenols | 5 | 2015 | 516 | 0.410 |
Why?
|
Chorionic Gonadotropin | 6 | 2017 | 457 | 0.410 |
Why?
|
Contraceptives, Oral | 4 | 2022 | 553 | 0.410 |
Why?
|
Progesterone | 5 | 2014 | 742 | 0.400 |
Why?
|
Postmenopause | 7 | 2016 | 2511 | 0.400 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.400 |
Why?
|
Pesticides | 3 | 2022 | 296 | 0.400 |
Why?
|
Pain | 9 | 2023 | 5062 | 0.400 |
Why?
|
Melanoma | 4 | 2021 | 5696 | 0.400 |
Why?
|
Pregnancy, Ectopic | 3 | 2018 | 142 | 0.400 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2017 | 2518 | 0.400 |
Why?
|
Psychotherapy, Brief | 1 | 2013 | 118 | 0.390 |
Why?
|
Patient Admission | 1 | 2019 | 1365 | 0.390 |
Why?
|
Skin Neoplasms | 5 | 2021 | 5811 | 0.390 |
Why?
|
Birth Weight | 7 | 2018 | 2101 | 0.390 |
Why?
|
Blastocyst | 5 | 2018 | 432 | 0.390 |
Why?
|
Ovulation Inhibition | 1 | 2011 | 4 | 0.390 |
Why?
|
Follow-Up Studies | 21 | 2022 | 39062 | 0.390 |
Why?
|
Genetic Predisposition to Disease | 15 | 2024 | 17878 | 0.390 |
Why?
|
Pesticide Residues | 2 | 2022 | 95 | 0.390 |
Why?
|
Skin Pigmentation | 1 | 2014 | 277 | 0.390 |
Why?
|
Hypertension | 7 | 2022 | 8532 | 0.380 |
Why?
|
Norethindrone | 3 | 2018 | 56 | 0.380 |
Why?
|
Probability | 2 | 2016 | 2475 | 0.380 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1884 | 0.380 |
Why?
|
Vitamin D | 3 | 2016 | 3301 | 0.380 |
Why?
|
Hormone Antagonists | 1 | 2011 | 106 | 0.370 |
Why?
|
Work Schedule Tolerance | 2 | 2015 | 552 | 0.370 |
Why?
|
Data Interpretation, Statistical | 3 | 2016 | 2689 | 0.370 |
Why?
|
Cesarean Section | 5 | 2022 | 1396 | 0.370 |
Why?
|
Single Embryo Transfer | 5 | 2018 | 29 | 0.370 |
Why?
|
Oocyte Donation | 4 | 2017 | 52 | 0.370 |
Why?
|
Heterosexuality | 6 | 2022 | 309 | 0.370 |
Why?
|
Erythrocytes | 1 | 2020 | 2410 | 0.370 |
Why?
|
Anxiety | 5 | 2021 | 4573 | 0.360 |
Why?
|
Sex Preselection | 2 | 2007 | 15 | 0.360 |
Why?
|
Estrone | 3 | 2008 | 234 | 0.360 |
Why?
|
Estradiol | 12 | 2023 | 1937 | 0.350 |
Why?
|
Sciatica | 1 | 2011 | 97 | 0.350 |
Why?
|
Multivariate Analysis | 17 | 2017 | 12043 | 0.350 |
Why?
|
Risk Assessment | 22 | 2021 | 23974 | 0.350 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2022 | 12143 | 0.350 |
Why?
|
Infant, Low Birth Weight | 6 | 2021 | 869 | 0.350 |
Why?
|
Sperm Injections, Intracytoplasmic | 7 | 2018 | 156 | 0.340 |
Why?
|
Inflammation | 5 | 2024 | 10759 | 0.340 |
Why?
|
Sperm Count | 1 | 2010 | 229 | 0.340 |
Why?
|
Massachusetts | 11 | 2022 | 8835 | 0.340 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2315 | 0.330 |
Why?
|
Vehicle Emissions | 1 | 2014 | 655 | 0.330 |
Why?
|
Attitude to Health | 3 | 2011 | 2025 | 0.330 |
Why?
|
Biomedical Research | 5 | 2024 | 3426 | 0.330 |
Why?
|
Sperm Motility | 1 | 2010 | 266 | 0.330 |
Why?
|
Logistic Models | 18 | 2023 | 13248 | 0.330 |
Why?
|
Insemination, Artificial | 5 | 2015 | 99 | 0.330 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2024 | 15908 | 0.320 |
Why?
|
Estrogens | 5 | 2020 | 1521 | 0.320 |
Why?
|
Breast Feeding | 1 | 2017 | 1355 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2016 | 4010 | 0.310 |
Why?
|
Length of Stay | 2 | 2019 | 6418 | 0.310 |
Why?
|
Inpatients | 2 | 2019 | 2545 | 0.310 |
Why?
|
Self Report | 7 | 2021 | 3727 | 0.310 |
Why?
|
Stillbirth | 3 | 2018 | 368 | 0.310 |
Why?
|
Maternal Exposure | 5 | 2011 | 1067 | 0.310 |
Why?
|
Ovulation Induction | 6 | 2020 | 277 | 0.310 |
Why?
|
Commodification | 1 | 2007 | 3 | 0.300 |
Why?
|
Embryo Research | 1 | 2008 | 38 | 0.300 |
Why?
|
Linear Models | 9 | 2024 | 5866 | 0.300 |
Why?
|
Myocardial Infarction | 4 | 2023 | 11458 | 0.300 |
Why?
|
Time-Lapse Imaging | 3 | 2017 | 194 | 0.300 |
Why?
|
Embryo Disposition | 1 | 2007 | 14 | 0.300 |
Why?
|
Obesity, Morbid | 2 | 2016 | 1276 | 0.300 |
Why?
|
Ovariectomy | 2 | 2023 | 613 | 0.290 |
Why?
|
Sexual Behavior | 7 | 2022 | 2187 | 0.290 |
Why?
|
Confidence Intervals | 8 | 2018 | 2925 | 0.290 |
Why?
|
Gonadotropin-Releasing Hormone | 4 | 2020 | 1148 | 0.290 |
Why?
|
Attitude | 3 | 2012 | 772 | 0.290 |
Why?
|
Food Contamination | 2 | 2006 | 191 | 0.290 |
Why?
|
Delivery, Obstetric | 4 | 2022 | 939 | 0.280 |
Why?
|
Patients | 1 | 2014 | 906 | 0.280 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2012 | 393 | 0.280 |
Why?
|
Culture | 1 | 2011 | 623 | 0.280 |
Why?
|
Cause of Death | 4 | 2024 | 3683 | 0.280 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2238 | 0.280 |
Why?
|
Adiponectin | 1 | 2012 | 1107 | 0.270 |
Why?
|
Depression | 4 | 2021 | 8132 | 0.270 |
Why?
|
Particulate Matter | 3 | 2019 | 2602 | 0.270 |
Why?
|
Neural Tube Defects | 2 | 2006 | 255 | 0.270 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2017 | 550 | 0.260 |
Why?
|
Sex Offenses | 3 | 2023 | 352 | 0.260 |
Why?
|
Hospitalization | 4 | 2022 | 10708 | 0.260 |
Why?
|
Premenstrual Syndrome | 2 | 2018 | 109 | 0.260 |
Why?
|
Sunlight | 2 | 2021 | 337 | 0.260 |
Why?
|
Endpoint Determination | 1 | 2008 | 590 | 0.250 |
Why?
|
Environmental Pollutants | 6 | 2013 | 1277 | 0.250 |
Why?
|
Amenorrhea | 3 | 2017 | 483 | 0.250 |
Why?
|
Maternal Age | 7 | 2021 | 809 | 0.250 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1529 | 0.250 |
Why?
|
Hair Color | 1 | 2006 | 131 | 0.250 |
Why?
|
Cytokines | 1 | 2020 | 7373 | 0.250 |
Why?
|
Health Surveys | 7 | 2021 | 4036 | 0.250 |
Why?
|
Overweight | 6 | 2020 | 2417 | 0.250 |
Why?
|
Models, Statistical | 5 | 2020 | 5074 | 0.250 |
Why?
|
Birth Rate | 5 | 2020 | 168 | 0.250 |
Why?
|
Resource Allocation | 1 | 2007 | 350 | 0.250 |
Why?
|
Eating | 3 | 2020 | 1535 | 0.250 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 2 | 2017 | 81 | 0.240 |
Why?
|
Androgens | 4 | 2010 | 1285 | 0.240 |
Why?
|
Workplace | 1 | 2011 | 863 | 0.240 |
Why?
|
Stroke | 3 | 2022 | 9715 | 0.240 |
Why?
|
Pain Threshold | 3 | 2023 | 603 | 0.240 |
Why?
|
Contraception Behavior | 2 | 2019 | 180 | 0.240 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2004 | 52 | 0.240 |
Why?
|
Child | 23 | 2023 | 80089 | 0.240 |
Why?
|
Educational Status | 2 | 2015 | 2509 | 0.240 |
Why?
|
Leptin | 1 | 2012 | 1595 | 0.230 |
Why?
|
Cystitis, Interstitial | 1 | 2024 | 66 | 0.230 |
Why?
|
Parabens | 2 | 2015 | 114 | 0.230 |
Why?
|
Retrospective Studies | 41 | 2022 | 80583 | 0.230 |
Why?
|
Preconception Care | 2 | 2016 | 141 | 0.230 |
Why?
|
Homosexuality, Female | 2 | 2019 | 171 | 0.220 |
Why?
|
Healthcare Disparities | 4 | 2019 | 3351 | 0.220 |
Why?
|
Boston | 12 | 2022 | 9313 | 0.220 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1110 | 0.210 |
Why?
|
Benzhydryl Compounds | 4 | 2013 | 915 | 0.210 |
Why?
|
Motor Activity | 2 | 2010 | 2714 | 0.210 |
Why?
|
Blood Specimen Collection | 2 | 2014 | 238 | 0.210 |
Why?
|
Tissue Preservation | 2 | 2016 | 174 | 0.210 |
Why?
|
Placenta | 2 | 2022 | 1709 | 0.210 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2015 | 2152 | 0.210 |
Why?
|
Research Design | 5 | 2020 | 6174 | 0.210 |
Why?
|
Menstruation | 1 | 2024 | 306 | 0.210 |
Why?
|
Work | 2 | 2015 | 195 | 0.200 |
Why?
|
Ovary | 2 | 2019 | 959 | 0.200 |
Why?
|
Patient Selection | 2 | 2011 | 4237 | 0.200 |
Why?
|
CA-125 Antigen | 2 | 2020 | 276 | 0.190 |
Why?
|
Preimplantation Diagnosis | 2 | 2015 | 143 | 0.190 |
Why?
|
Weight Gain | 4 | 2016 | 2349 | 0.190 |
Why?
|
Environment | 2 | 2018 | 1123 | 0.190 |
Why?
|
Ovarian Hyperstimulation Syndrome | 2 | 2014 | 47 | 0.190 |
Why?
|
Quantitative Trait, Heritable | 2 | 2014 | 540 | 0.190 |
Why?
|
Photoperiod | 1 | 2021 | 139 | 0.180 |
Why?
|
Eggs | 2 | 2018 | 182 | 0.180 |
Why?
|
Proteomics | 4 | 2024 | 3836 | 0.180 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2014 | 389 | 0.180 |
Why?
|
Time Factors | 16 | 2021 | 39908 | 0.180 |
Why?
|
Pregnancy Reduction, Multifetal | 2 | 2010 | 16 | 0.180 |
Why?
|
Medical History Taking | 2 | 2014 | 773 | 0.180 |
Why?
|
Triplets | 2 | 2010 | 42 | 0.180 |
Why?
|
Embryonic Development | 3 | 2017 | 720 | 0.180 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2021 | 284 | 0.180 |
Why?
|
Pain, Intractable | 1 | 2021 | 132 | 0.180 |
Why?
|
Domestic Violence | 2 | 2014 | 180 | 0.180 |
Why?
|
Fertility Agents, Female | 4 | 2014 | 101 | 0.170 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 783 | 0.170 |
Why?
|
Residence Characteristics | 3 | 2018 | 2092 | 0.170 |
Why?
|
Information Storage and Retrieval | 3 | 2014 | 819 | 0.170 |
Why?
|
Urinary Incontinence, Stress | 1 | 2022 | 174 | 0.170 |
Why?
|
Receptors, Progesterone | 1 | 2004 | 1129 | 0.170 |
Why?
|
Embryo, Mammalian | 3 | 2011 | 1670 | 0.170 |
Why?
|
Specimen Handling | 2 | 2014 | 701 | 0.170 |
Why?
|
Research | 2 | 2020 | 1977 | 0.170 |
Why?
|
Midwestern United States | 2 | 2011 | 70 | 0.170 |
Why?
|
Nevus, Pigmented | 2 | 2014 | 222 | 0.170 |
Why?
|
Testosterone | 4 | 2023 | 2472 | 0.170 |
Why?
|
Hormones | 2 | 2022 | 869 | 0.160 |
Why?
|
Culture Media, Conditioned | 1 | 2020 | 522 | 0.160 |
Why?
|
Trans Fatty Acids | 1 | 2020 | 155 | 0.160 |
Why?
|
Treatment Outcome | 25 | 2018 | 64572 | 0.160 |
Why?
|
Academic Medical Centers | 2 | 2015 | 2756 | 0.160 |
Why?
|
Papillomavirus Vaccines | 2 | 2019 | 496 | 0.160 |
Why?
|
Estrogen Receptor alpha | 2 | 2020 | 583 | 0.160 |
Why?
|
Feeding Behavior | 3 | 2024 | 3183 | 0.160 |
Why?
|
Meat | 1 | 2002 | 584 | 0.160 |
Why?
|
Diagnostic Techniques, Surgical | 1 | 2018 | 9 | 0.160 |
Why?
|
Education | 3 | 2016 | 534 | 0.160 |
Why?
|
Seasons | 2 | 2021 | 1518 | 0.160 |
Why?
|
Caffeine | 2 | 2016 | 699 | 0.160 |
Why?
|
Blood Proteins | 1 | 2024 | 1172 | 0.160 |
Why?
|
Salivary alpha-Amylases | 1 | 2018 | 15 | 0.160 |
Why?
|
Proteome | 1 | 2008 | 1857 | 0.160 |
Why?
|
Smoking | 7 | 2020 | 9054 | 0.150 |
Why?
|
Shellfish | 1 | 2018 | 37 | 0.150 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2018 | 29 | 0.150 |
Why?
|
Dental Health Surveys | 1 | 2018 | 39 | 0.150 |
Why?
|
Pregnancy, Unplanned | 1 | 2019 | 85 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 778 | 0.150 |
Why?
|
Cumulus Cells | 1 | 2018 | 22 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 344 | 0.150 |
Why?
|
Surrogate Mothers | 1 | 2018 | 16 | 0.150 |
Why?
|
Creatinine | 1 | 2024 | 1895 | 0.150 |
Why?
|
Cotinine | 4 | 2012 | 206 | 0.150 |
Why?
|
Leuprolide | 2 | 2018 | 312 | 0.150 |
Why?
|
Phthalic Acids | 2 | 2015 | 478 | 0.150 |
Why?
|
Temperature | 2 | 2021 | 2224 | 0.150 |
Why?
|
Exercise | 3 | 2010 | 5886 | 0.150 |
Why?
|
Zona Pellucida | 1 | 2017 | 14 | 0.150 |
Why?
|
Crime Victims | 2 | 2014 | 347 | 0.150 |
Why?
|
Nuclear Family | 1 | 2019 | 311 | 0.150 |
Why?
|
Pregnancy Trimester, First | 2 | 2013 | 908 | 0.150 |
Why?
|
Hospital Charges | 1 | 2019 | 350 | 0.140 |
Why?
|
Directed Tissue Donation | 1 | 2017 | 18 | 0.140 |
Why?
|
Quantitative Trait Loci | 2 | 2016 | 2112 | 0.140 |
Why?
|
Biopsy | 2 | 2021 | 6763 | 0.140 |
Why?
|
Fetal Mortality | 2 | 2014 | 19 | 0.140 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 602 | 0.140 |
Why?
|
Insemination, Artificial, Homologous | 2 | 2015 | 17 | 0.140 |
Why?
|
Health Care Costs | 3 | 2019 | 3238 | 0.140 |
Why?
|
Male | 50 | 2023 | 360402 | 0.140 |
Why?
|
Erectile Dysfunction | 1 | 2020 | 444 | 0.140 |
Why?
|
Epithelium | 1 | 2021 | 1603 | 0.140 |
Why?
|
Embryo Culture Techniques | 1 | 2017 | 84 | 0.140 |
Why?
|
Reproductive Behavior | 1 | 2016 | 27 | 0.140 |
Why?
|
Compensation and Redress | 1 | 2017 | 66 | 0.140 |
Why?
|
Goals | 1 | 2022 | 708 | 0.140 |
Why?
|
Neuralgia | 1 | 2023 | 611 | 0.140 |
Why?
|
Interleukin-8 | 1 | 2019 | 696 | 0.140 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2018 | 276 | 0.130 |
Why?
|
Receptors, Estrogen | 1 | 2004 | 2208 | 0.130 |
Why?
|
China | 1 | 2022 | 2374 | 0.130 |
Why?
|
Birth Order | 1 | 2016 | 95 | 0.130 |
Why?
|
Environment Design | 1 | 2018 | 173 | 0.130 |
Why?
|
Urinary Bladder Diseases | 1 | 2017 | 167 | 0.130 |
Why?
|
Phenotype | 6 | 2024 | 16572 | 0.130 |
Why?
|
Gestational Age | 8 | 2018 | 3577 | 0.130 |
Why?
|
Epidemiologic Studies | 2 | 2017 | 673 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 2270 | 0.130 |
Why?
|
Placebo Effect | 1 | 2020 | 518 | 0.130 |
Why?
|
Private Sector | 1 | 2019 | 394 | 0.130 |
Why?
|
Flavonoids | 1 | 2009 | 445 | 0.130 |
Why?
|
Child Abuse | 2 | 2023 | 1076 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1079 | 0.130 |
Why?
|
Contraception | 1 | 2019 | 347 | 0.130 |
Why?
|
Adenoma | 2 | 2016 | 2159 | 0.130 |
Why?
|
Robotics | 2 | 2013 | 817 | 0.130 |
Why?
|
Occupational Exposure | 2 | 2017 | 1813 | 0.130 |
Why?
|
Genital Neoplasms, Female | 1 | 2021 | 532 | 0.130 |
Why?
|
Patient Satisfaction | 2 | 2007 | 3451 | 0.130 |
Why?
|
Fumonisins | 2 | 2006 | 10 | 0.130 |
Why?
|
Disinfectants | 1 | 2017 | 129 | 0.130 |
Why?
|
Infant, Small for Gestational Age | 1 | 2018 | 462 | 0.130 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.120 |
Why?
|
Puerperal Disorders | 1 | 2018 | 300 | 0.120 |
Why?
|
Research Personnel | 1 | 2020 | 588 | 0.120 |
Why?
|
Lifting | 1 | 2015 | 55 | 0.120 |
Why?
|
Age Distribution | 5 | 2018 | 2872 | 0.120 |
Why?
|
Fishes | 1 | 2018 | 602 | 0.120 |
Why?
|
Regression Analysis | 3 | 2013 | 6339 | 0.120 |
Why?
|
Gastroplasty | 1 | 2016 | 157 | 0.120 |
Why?
|
Bisexuality | 3 | 2022 | 294 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 679 | 0.120 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 1007 | 0.120 |
Why?
|
Zea mays | 2 | 2006 | 110 | 0.120 |
Why?
|
Endocrinology | 2 | 2013 | 442 | 0.120 |
Why?
|
Treatment Failure | 3 | 2011 | 2635 | 0.120 |
Why?
|
Consensus | 3 | 2021 | 3117 | 0.120 |
Why?
|
Dehydroepiandrosterone | 2 | 2006 | 258 | 0.120 |
Why?
|
Human Growth Hormone | 2 | 2017 | 642 | 0.120 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9586 | 0.120 |
Why?
|
Ideal Body Weight | 1 | 2014 | 27 | 0.110 |
Why?
|
Vaccination | 3 | 2024 | 3370 | 0.110 |
Why?
|
Norway | 3 | 2020 | 499 | 0.110 |
Why?
|
Telomere | 1 | 2020 | 942 | 0.110 |
Why?
|
Dietary Supplements | 3 | 2020 | 3412 | 0.110 |
Why?
|
Sesamum | 1 | 2013 | 20 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2019 | 912 | 0.110 |
Why?
|
Genetic Markers | 1 | 2020 | 2601 | 0.110 |
Why?
|
Nursing Staff, Hospital | 1 | 2017 | 348 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 3 | 2016 | 726 | 0.110 |
Why?
|
Nut Hypersensitivity | 1 | 2013 | 33 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1566 | 0.110 |
Why?
|
Fetal Resorption | 1 | 2013 | 15 | 0.110 |
Why?
|
Sexuality | 2 | 2013 | 180 | 0.110 |
Why?
|
Chronic Disease | 3 | 2019 | 9310 | 0.110 |
Why?
|
Colonic Pouches | 1 | 2014 | 122 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1834 | 0.110 |
Why?
|
Methotrexate | 2 | 2017 | 1716 | 0.110 |
Why?
|
Colitis, Ulcerative | 2 | 2016 | 1921 | 0.110 |
Why?
|
Folic Acid | 2 | 2014 | 1323 | 0.110 |
Why?
|
Interleukin-6 | 3 | 2018 | 3205 | 0.110 |
Why?
|
Granulosa Cells | 1 | 2013 | 115 | 0.110 |
Why?
|
Aromatase | 1 | 2013 | 147 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2016 | 329 | 0.110 |
Why?
|
Posthumous Conception | 1 | 2012 | 11 | 0.100 |
Why?
|
Fathers | 1 | 2015 | 375 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2024 | 3115 | 0.100 |
Why?
|
Cost of Illness | 2 | 2020 | 1937 | 0.100 |
Why?
|
Gonadotropins | 2 | 2014 | 241 | 0.100 |
Why?
|
Fallopian Tubes | 1 | 2013 | 178 | 0.100 |
Why?
|
Contraceptives, Oral, Synthetic | 1 | 2011 | 16 | 0.100 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 730 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2577 | 0.100 |
Why?
|
Luteal Phase | 1 | 2012 | 138 | 0.100 |
Why?
|
Angina Pectoris | 1 | 2016 | 959 | 0.100 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2012 | 82 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1810 | 0.100 |
Why?
|
Nutritional Status | 1 | 2000 | 1597 | 0.100 |
Why?
|
Cyprus | 2 | 2024 | 96 | 0.100 |
Why?
|
Mood Disorders | 1 | 2018 | 1127 | 0.100 |
Why?
|
Metrorrhagia | 1 | 2011 | 17 | 0.100 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 557 | 0.100 |
Why?
|
Transcription Factors | 2 | 2022 | 12116 | 0.100 |
Why?
|
Polychlorinated Biphenyls | 2 | 2011 | 236 | 0.100 |
Why?
|
Hydrocortisone | 2 | 2018 | 1819 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2764 | 0.100 |
Why?
|
Pregnancy in Adolescence | 1 | 2013 | 163 | 0.100 |
Why?
|
Severity of Illness Index | 6 | 2020 | 15829 | 0.100 |
Why?
|
Particle Size | 1 | 2016 | 1648 | 0.090 |
Why?
|
Aged | 19 | 2021 | 169092 | 0.090 |
Why?
|
Pain Measurement | 3 | 2023 | 3546 | 0.090 |
Why?
|
Twins, Monozygotic | 2 | 2010 | 470 | 0.090 |
Why?
|
C-Reactive Protein | 3 | 2018 | 3820 | 0.090 |
Why?
|
Health Policy | 1 | 2023 | 2682 | 0.090 |
Why?
|
Placenta Accreta | 1 | 2015 | 237 | 0.090 |
Why?
|
Body Height | 1 | 2017 | 1565 | 0.090 |
Why?
|
Twins | 2 | 2013 | 340 | 0.090 |
Why?
|
Genotype | 4 | 2017 | 12977 | 0.090 |
Why?
|
Menorrhagia | 2 | 2019 | 59 | 0.090 |
Why?
|
Triglycerides | 1 | 2018 | 2459 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2955 | 0.090 |
Why?
|
Aspirin | 1 | 2022 | 3127 | 0.090 |
Why?
|
Functional Laterality | 1 | 2017 | 2256 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2045 | 0.090 |
Why?
|
Peanut Hypersensitivity | 1 | 2013 | 219 | 0.090 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2013 | 328 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1483 | 0.090 |
Why?
|
Physicians | 2 | 2023 | 4583 | 0.080 |
Why?
|
Body Weight | 2 | 2017 | 4615 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2006 | 2851 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2016 | 1300 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7390 | 0.080 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2010 | 361 | 0.080 |
Why?
|
Photosensitivity Disorders | 1 | 2009 | 80 | 0.080 |
Why?
|
Bicycling | 1 | 2010 | 177 | 0.080 |
Why?
|
Acne Vulgaris | 1 | 2014 | 349 | 0.080 |
Why?
|
Thyrotropin | 1 | 2012 | 834 | 0.080 |
Why?
|
Internationality | 4 | 2014 | 1000 | 0.080 |
Why?
|
Social Stigma | 3 | 2021 | 769 | 0.080 |
Why?
|
Diet Surveys | 1 | 2013 | 1161 | 0.080 |
Why?
|
Family Characteristics | 1 | 2014 | 992 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2019 | 2020 | 0.080 |
Why?
|
Criminals | 1 | 2009 | 62 | 0.080 |
Why?
|
Child, Preschool | 5 | 2021 | 42193 | 0.080 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7805 | 0.080 |
Why?
|
Validation Studies as Topic | 1 | 2008 | 162 | 0.080 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2009 | 121 | 0.080 |
Why?
|
Organ Size | 1 | 2013 | 2252 | 0.080 |
Why?
|
Fertilization | 3 | 2015 | 198 | 0.080 |
Why?
|
Melanosis | 1 | 2009 | 93 | 0.080 |
Why?
|
Inhalation Exposure | 1 | 2011 | 432 | 0.080 |
Why?
|
Mothers | 1 | 2019 | 2194 | 0.080 |
Why?
|
Illinois | 1 | 2008 | 120 | 0.080 |
Why?
|
Gastric Bypass | 1 | 2016 | 818 | 0.070 |
Why?
|
Ultrasonography | 3 | 2019 | 5965 | 0.070 |
Why?
|
Stress, Psychological | 2 | 2014 | 4488 | 0.070 |
Why?
|
Tissue Donors | 3 | 2017 | 2329 | 0.070 |
Why?
|
Environmental Monitoring | 1 | 2014 | 1460 | 0.070 |
Why?
|
Circadian Rhythm | 3 | 2018 | 2569 | 0.070 |
Why?
|
Placentation | 1 | 2008 | 78 | 0.070 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5430 | 0.070 |
Why?
|
Vitamin D-Binding Protein | 1 | 2008 | 131 | 0.070 |
Why?
|
Texas | 2 | 2006 | 403 | 0.070 |
Why?
|
Students | 1 | 2017 | 1736 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 1372 | 0.070 |
Why?
|
Cytoskeleton | 1 | 2012 | 1170 | 0.070 |
Why?
|
Health Status | 1 | 2000 | 4076 | 0.070 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.070 |
Why?
|
Demography | 2 | 2018 | 1643 | 0.070 |
Why?
|
Chromosomes, Human, Y | 1 | 2008 | 161 | 0.070 |
Why?
|
Decision Making | 1 | 2021 | 3919 | 0.070 |
Why?
|
Emotions | 2 | 2020 | 2741 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2495 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2188 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2010 | 726 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2011 | 3882 | 0.070 |
Why?
|
Postpartum Period | 1 | 2013 | 1178 | 0.070 |
Why?
|
Complement C3 | 1 | 2008 | 434 | 0.070 |
Why?
|
Menarche | 2 | 2012 | 532 | 0.070 |
Why?
|
Human Development | 1 | 2007 | 123 | 0.070 |
Why?
|
Thinness | 1 | 2010 | 480 | 0.070 |
Why?
|
Mexico | 2 | 2006 | 757 | 0.070 |
Why?
|
Software | 2 | 2017 | 4432 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3333 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3680 | 0.070 |
Why?
|
Prognosis | 3 | 2021 | 29601 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12333 | 0.070 |
Why?
|
Abdominal Pain | 2 | 2023 | 1070 | 0.060 |
Why?
|
Antithrombins | 1 | 2008 | 292 | 0.060 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 6927 | 0.060 |
Why?
|
Medicaid | 1 | 2019 | 2814 | 0.060 |
Why?
|
Comprehension | 1 | 2011 | 620 | 0.060 |
Why?
|
Mammography | 1 | 2016 | 2430 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8998 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2018 | 1701 | 0.060 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2006 | 241 | 0.060 |
Why?
|
Growth Hormone | 1 | 2007 | 569 | 0.060 |
Why?
|
Reference Values | 3 | 2023 | 4919 | 0.060 |
Why?
|
Survivors | 2 | 2015 | 2373 | 0.060 |
Why?
|
Pilot Projects | 3 | 2017 | 8619 | 0.060 |
Why?
|
Rabbits | 2 | 2020 | 4770 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2020 | 18937 | 0.060 |
Why?
|
Causality | 1 | 2011 | 1241 | 0.060 |
Why?
|
Paris | 1 | 2024 | 41 | 0.060 |
Why?
|
Disease Progression | 2 | 2020 | 13495 | 0.060 |
Why?
|
Carotenoids | 1 | 2007 | 621 | 0.060 |
Why?
|
Body Constitution | 1 | 2004 | 273 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3177 | 0.060 |
Why?
|
Clinical Competence | 2 | 2017 | 4790 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2016 | 2423 | 0.060 |
Why?
|
Fellowships and Scholarships | 2 | 2013 | 1116 | 0.050 |
Why?
|
Crohn Disease | 1 | 2016 | 2279 | 0.050 |
Why?
|
Analgesics | 1 | 2010 | 1067 | 0.050 |
Why?
|
Homosexuality, Male | 1 | 2011 | 1333 | 0.050 |
Why?
|
Violence | 1 | 2009 | 936 | 0.050 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2014 | 310 | 0.050 |
Why?
|
Saliva | 2 | 2018 | 828 | 0.050 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1737 | 0.050 |
Why?
|
Sphingolipids | 1 | 2004 | 173 | 0.050 |
Why?
|
Health Status Disparities | 2 | 2011 | 1846 | 0.050 |
Why?
|
Paclitaxel | 1 | 2010 | 1730 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2019 | 2079 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6561 | 0.050 |
Why?
|
Lactation | 1 | 2004 | 397 | 0.050 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2022 | 113 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3533 | 0.050 |
Why?
|
Injections, Intramuscular | 2 | 2014 | 555 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4021 | 0.050 |
Why?
|
Pain Perception | 1 | 2023 | 196 | 0.050 |
Why?
|
DNA | 2 | 2022 | 7196 | 0.050 |
Why?
|
Tea | 2 | 2016 | 287 | 0.050 |
Why?
|
Education, Medical | 1 | 2013 | 1725 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4309 | 0.050 |
Why?
|
Control Groups | 1 | 2021 | 104 | 0.050 |
Why?
|
Patient Compliance | 1 | 2011 | 2688 | 0.050 |
Why?
|
Obstetrics | 1 | 2008 | 666 | 0.050 |
Why?
|
Sex Factors | 4 | 2016 | 10549 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4575 | 0.040 |
Why?
|
Genome, Human | 2 | 2010 | 4421 | 0.040 |
Why?
|
Pelvic Floor | 1 | 2021 | 138 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.040 |
Why?
|
Databases, Factual | 4 | 2018 | 7963 | 0.040 |
Why?
|
Glutens | 1 | 2022 | 240 | 0.040 |
Why?
|
Glycemic Index | 1 | 2022 | 396 | 0.040 |
Why?
|
HIV Infections | 2 | 2011 | 17342 | 0.040 |
Why?
|
Hot Flashes | 1 | 2023 | 330 | 0.040 |
Why?
|
Animals | 7 | 2023 | 168202 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2017 | 11512 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2005 | 751 | 0.040 |
Why?
|
Antioxidants | 1 | 2007 | 1669 | 0.040 |
Why?
|
Apigenin | 1 | 2009 | 16 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2003 | 368 | 0.040 |
Why?
|
Flavones | 1 | 2009 | 68 | 0.040 |
Why?
|
Lipids | 2 | 2022 | 3332 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 11735 | 0.040 |
Why?
|
Data Collection | 3 | 2015 | 3316 | 0.040 |
Why?
|
Milk | 1 | 2002 | 442 | 0.040 |
Why?
|
Hyperalgesia | 1 | 2023 | 526 | 0.040 |
Why?
|
Nucleosomes | 1 | 2022 | 487 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13635 | 0.040 |
Why?
|
Coffee | 2 | 2016 | 592 | 0.040 |
Why?
|
alpha-Amylases | 1 | 2018 | 39 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 150 | 0.040 |
Why?
|
Nutrition Surveys | 2 | 2020 | 1725 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 1612 | 0.040 |
Why?
|
Dietary Fiber | 1 | 2022 | 758 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10072 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2005 | 1208 | 0.040 |
Why?
|
Selection, Genetic | 1 | 2023 | 868 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2017 | 2422 | 0.040 |
Why?
|
Puerto Rico | 1 | 2019 | 378 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 634 | 0.040 |
Why?
|
Denervation | 1 | 2019 | 265 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.040 |
Why?
|
Contraceptive Agents | 1 | 2019 | 144 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2022 | 891 | 0.040 |
Why?
|
Pelvis | 1 | 2022 | 732 | 0.040 |
Why?
|
Intrauterine Devices | 1 | 2018 | 112 | 0.040 |
Why?
|
Sjogren's Syndrome | 1 | 2019 | 237 | 0.040 |
Why?
|
Population Density | 1 | 2018 | 193 | 0.040 |
Why?
|
Abdomen | 1 | 2023 | 1128 | 0.040 |
Why?
|
Recurrence | 2 | 2021 | 8426 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2008 | 2674 | 0.040 |
Why?
|
Embryoid Bodies | 1 | 2017 | 65 | 0.030 |
Why?
|
Infant, Premature | 2 | 2020 | 2107 | 0.030 |
Why?
|
Cystoscopy | 1 | 2017 | 130 | 0.030 |
Why?
|
Progestins | 1 | 2019 | 301 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20077 | 0.030 |
Why?
|
Respiratory Protective Devices | 1 | 2017 | 47 | 0.030 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2017 | 64 | 0.030 |
Why?
|
Cleavage Stage, Ovum | 1 | 2016 | 44 | 0.030 |
Why?
|
Protective Clothing | 1 | 2017 | 103 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 183 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2017 | 370 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3735 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1812 | 0.030 |
Why?
|
Ethinyl Estradiol | 1 | 2016 | 113 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6403 | 0.030 |
Why?
|
Ovarian Follicle | 2 | 2009 | 244 | 0.030 |
Why?
|
Asthma | 1 | 2015 | 6234 | 0.030 |
Why?
|
Suction | 1 | 2017 | 266 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2006 | 3239 | 0.030 |
Why?
|
Culture Media | 1 | 2018 | 895 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15250 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1077 | 0.030 |
Why?
|
Mass Screening | 1 | 2011 | 5425 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 530 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2017 | 4611 | 0.030 |
Why?
|
Mental Health | 2 | 2021 | 3253 | 0.030 |
Why?
|
Carbonated Beverages | 1 | 2016 | 210 | 0.030 |
Why?
|
Shame | 1 | 2015 | 80 | 0.030 |
Why?
|
Menopause | 1 | 2023 | 1645 | 0.030 |
Why?
|
Longevity | 1 | 2022 | 1064 | 0.030 |
Why?
|
Urologic Surgical Procedures | 1 | 2017 | 296 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3410 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 744 | 0.030 |
Why?
|
Paternal Exposure | 1 | 2015 | 96 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1128 | 0.030 |
Why?
|
Clomiphene | 1 | 2014 | 71 | 0.030 |
Why?
|
Religion | 1 | 2017 | 376 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15609 | 0.030 |
Why?
|
Skinfold Thickness | 1 | 2014 | 163 | 0.030 |
Why?
|
Health Benefit Plans, Employee | 1 | 2016 | 332 | 0.030 |
Why?
|
Urine | 1 | 2015 | 362 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 2 | 2013 | 1754 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 763 | 0.030 |
Why?
|
Term Birth | 1 | 2013 | 138 | 0.030 |
Why?
|
Placenta Diseases | 1 | 2015 | 199 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9171 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 2014 | 248 | 0.030 |
Why?
|
Spermatozoa | 1 | 2017 | 629 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.030 |
Why?
|
Proctocolectomy, Restorative | 1 | 2014 | 190 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2016 | 553 | 0.030 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
Abortion, Induced | 1 | 2018 | 461 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 2009 | 4416 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7569 | 0.030 |
Why?
|
Polybrominated Biphenyls | 1 | 2012 | 25 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 478 | 0.030 |
Why?
|
Vaginal Creams, Foams, and Jellies | 1 | 2012 | 62 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1380 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 4845 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 671 | 0.030 |
Why?
|
Sex Distribution | 1 | 2017 | 2278 | 0.030 |
Why?
|
Genomics | 2 | 2024 | 5822 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2016 | 702 | 0.020 |
Why?
|
DDT | 1 | 2011 | 32 | 0.020 |
Why?
|
Hexachlorobenzene | 1 | 2011 | 27 | 0.020 |
Why?
|
Internet | 2 | 2017 | 3094 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2012 | 313 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2013 | 361 | 0.020 |
Why?
|
Financing, Personal | 1 | 2014 | 308 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1265 | 0.020 |
Why?
|
Health Literacy | 1 | 2017 | 443 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2012 | 367 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10754 | 0.020 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2013 | 217 | 0.020 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2011 | 86 | 0.020 |
Why?
|
Meiosis | 1 | 2013 | 327 | 0.020 |
Why?
|
Skin Tests | 1 | 2013 | 637 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2419 | 0.020 |
Why?
|
Beverages | 1 | 2016 | 821 | 0.020 |
Why?
|
Life Change Events | 1 | 2016 | 953 | 0.020 |
Why?
|
New England | 1 | 2014 | 1050 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1635 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2012 | 535 | 0.020 |
Why?
|
Twinning, Monozygotic | 1 | 2010 | 17 | 0.020 |
Why?
|
Patient Rights | 1 | 2011 | 125 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 565 | 0.020 |
Why?
|
Inservice Training | 1 | 2013 | 375 | 0.020 |
Why?
|
Learning Curve | 1 | 2012 | 230 | 0.020 |
Why?
|
Affect | 1 | 2018 | 1486 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 638 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 151 | 0.020 |
Why?
|
Employment | 1 | 2017 | 1113 | 0.020 |
Why?
|
Chromosomes | 1 | 2013 | 578 | 0.020 |
Why?
|
Carcinoma, Endometrioid | 1 | 2013 | 276 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8516 | 0.020 |
Why?
|
Twins, Dizygotic | 1 | 2010 | 236 | 0.020 |
Why?
|
Population Surveillance | 1 | 2000 | 2597 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2010 | 861 | 0.020 |
Why?
|
Algorithms | 3 | 2020 | 14024 | 0.020 |
Why?
|
DNA Methylation | 1 | 2023 | 4392 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2378 | 0.020 |
Why?
|
Family | 1 | 2020 | 3193 | 0.020 |
Why?
|
Cholesterol | 1 | 2018 | 2902 | 0.020 |
Why?
|
Ovulation | 1 | 2009 | 181 | 0.020 |
Why?
|
Electrocoagulation | 1 | 2009 | 152 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2013 | 517 | 0.020 |
Why?
|
Heart Rate, Fetal | 1 | 2009 | 75 | 0.020 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2009 | 155 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1199 | 0.020 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2009 | 116 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 957 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11069 | 0.020 |
Why?
|
Lasers, Gas | 1 | 2009 | 101 | 0.020 |
Why?
|
Chorion | 1 | 2008 | 114 | 0.020 |
Why?
|
Colonoscopy | 1 | 2016 | 1397 | 0.020 |
Why?
|
Climacteric | 1 | 2007 | 57 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2008 | 277 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 983 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2014 | 738 | 0.020 |
Why?
|
Internship and Residency | 1 | 2008 | 5878 | 0.020 |
Why?
|
Fetal Heart | 1 | 2009 | 281 | 0.020 |
Why?
|
Chimerism | 1 | 2008 | 155 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3575 | 0.020 |
Why?
|
Australia | 1 | 2010 | 1249 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2724 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3776 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2004 | 18220 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1834 | 0.020 |
Why?
|
Educational Measurement | 1 | 2013 | 1252 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2017 | 2768 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2734 | 0.020 |
Why?
|
Minority Groups | 1 | 2013 | 1202 | 0.020 |
Why?
|
Acetaminophen | 1 | 2010 | 555 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1662 | 0.020 |
Why?
|
Income | 1 | 2014 | 1870 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2639 | 0.020 |
Why?
|
Brazil | 1 | 2009 | 1229 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2011 | 661 | 0.020 |
Why?
|
Social Control, Formal | 1 | 2005 | 108 | 0.020 |
Why?
|
Radiotherapy | 1 | 2011 | 1497 | 0.010 |
Why?
|
Postal Service | 1 | 2005 | 96 | 0.010 |
Why?
|
Adiposity | 1 | 2014 | 1879 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23716 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4524 | 0.010 |
Why?
|
Mice | 3 | 2020 | 81368 | 0.010 |
Why?
|
Signal Transduction | 2 | 2019 | 23415 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4810 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8700 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3739 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2632 | 0.010 |
Why?
|
Culture Techniques | 1 | 2004 | 531 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14649 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6861 | 0.010 |
Why?
|
Industry | 1 | 2005 | 364 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15577 | 0.010 |
Why?
|
Patient Advocacy | 1 | 2005 | 360 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3805 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2340 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9461 | 0.010 |
Why?
|
Social Responsibility | 1 | 2005 | 385 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2014 | 1937 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8652 | 0.010 |
Why?
|
Pediatrics | 1 | 2017 | 3589 | 0.010 |
Why?
|
Follicular Phase | 1 | 2002 | 143 | 0.010 |
Why?
|
Craniofacial Abnormalities | 1 | 2004 | 319 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2413 | 0.010 |
Why?
|
Trust | 1 | 2006 | 529 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2034 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3607 | 0.010 |
Why?
|
Fear | 1 | 2009 | 1477 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36401 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7873 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2002 | 820 | 0.010 |
Why?
|
Biological Transport | 1 | 2004 | 2089 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 4937 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58919 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4058 | 0.010 |
Why?
|
Drug Industry | 1 | 2005 | 788 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22117 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 3196 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10203 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6074 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5239 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12759 | 0.010 |
Why?
|
Pedigree | 1 | 2006 | 4539 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36157 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4242 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30015 | 0.010 |
Why?
|
Social Class | 1 | 2005 | 1993 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7847 | 0.010 |
Why?
|
Parents | 1 | 2007 | 3563 | 0.010 |
Why?
|